Published in J Exp Med on May 01, 1964
Bacteriophage control of bacterial virulence. Infect Immun (2002) 2.97
Inducible lysis clostridium tetani. J Bacteriol (1967) 2.78
Effect of a recA mutation on cholera toxin gene amplification and deletion events. J Bacteriol (1986) 2.22
Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages. Appl Microbiol (1974) 2.08
Staphylococcal enterotoxin A gene is associated with a variable genetic element. Proc Natl Acad Sci U S A (1984) 1.79
The gene for type A streptococcal exotoxin (erythrogenic toxin) is located in bacteriophage T12. Infect Immun (1984) 1.72
Intergroup phage reactions and transduction between group C and group A streptococci. J Exp Med (1973) 1.72
Bacteriophage involvement in group A streptococcal pyrogenic exotoxin A production. J Bacteriol (1986) 1.49
Induction of lysogenic bacteriophage and phage-associated toxin from group a streptococci during coculture with human pharyngeal cells. Infect Immun (2001) 1.46
The in vitro interaction of Streptococcus pyogenes with human pharyngeal cells induces a phage-encoded extracellular DNase. Infect Immun (2002) 1.26
Lysogenic transfer of group A Streptococcus superantigen gene among Streptococci. J Infect Dis (2008) 1.24
Bacteriophage deoxyribonucleic acid-induced mutation of Streptococcus mutans. Infect Immun (1977) 1.20
A globally disseminated M1 subclone of group A streptococci differs from other subclones by 70 kilobases of prophage DNA and capacity for high-frequency intracellular invasion. Infect Immun (1998) 1.19
Phage influence on the synthesis of extracellular toxins in group A streptococci. Infect Immun (1982) 1.19
Enzyme-linked immunosorbent assay for detection of type A streptococcal exotoxin: kinetics and regulation during growth of Streptococcus pyogenes. Infect Immun (1981) 1.15
Transfer of group A streptococcal pyrogenic exotoxin production to nontoxigenic strains of lysogenic conversion. Infect Immun (1980) 1.14
Genetic basis of toxin production and pathogenesis in Vibrio cholerae: evidence against phage conversion. Infect Immun (1975) 1.12
Studies on streptococcal bacteriophages. II. Adsorption studies on group A and group C streptococcal bacteriophages. J Exp Med (1968) 1.07
Glycerol monolaurate antibacterial activity in broth and biofilm cultures. PLoS One (2012) 1.07
Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen. Infect Immun (2001) 1.01
Studies on streptococcal bacteriophages. I. Burst size and intracellular growth of group A and group C streptococcal bacteriophages. J Exp Med (1968) 0.96
Characterization of an inducible bacteriophage from a leukotoxic strain of Actinobacillus actinomycetemcomitans. Infect Immun (1982) 0.95
Characterization of group H streptococcal temperate bacteriophage phi 227. J Virol (1977) 0.93
Phage-host interactions and the production of type A streptococcal exotoxin in group A streptococci. Infect Immun (1981) 0.89
Superantigens in human disease. J Clin Immunol (1999) 0.88
Effect of resistance to chloramphenicol on bacteriophage sensitivity of group A streptococci. J Virol (1967) 0.85
Lysogenic transfer of mef(A) and tet(O) genes carried by Phim46.1 among group A streptococci. Antimicrob Agents Chemother (2010) 0.83
Transcriptional regulation of a bacteriophage encoded extracellular DNase (Spd-3) by Rgg in Streptococcus pyogenes. PLoS One (2013) 0.76
Genetic diversity in temperate bacteriophages of Streptococcus pyogenes: identification of a second attachment site for phages carrying the erythrogenic toxin A gene. J Bacteriol (1997) 0.76
Salmonella toxin synthesis is unrelated to the presence of temperate bacteriophages. Infect Immun (1982) 0.75
Replica plating and indirect selection of bacterial mutants. J Bacteriol (1952) 59.66
TYPING GROUP A HEMOLYTIC STREPTOCOCCI BY M PRECIPITIN REACTIONS IN CAPILLARY PIPETTES. J Exp Med (1943) 17.30
Evidence for the induced nature of the change from nontoxigenicity to toxigenicity in Corynebacterium diphtheriae as a result of exposure to specific bacteriophage. J Bacteriol (1953) 5.66
Further observations on the change to virulence of bacteriophage-infected a virulent strains of Corynebacterium diphtheria. J Bacteriol (1952) 3.57
Studies on streptococcal bacteriophages. I. Technique of isolating phage-producing strains. Acta Pathol Microbiol Scand (1955) 3.54
The crystallization and serological differentiation of a streptococcal proteinase and its precursor. J Exp Med (1950) 3.30
Electrophoretic studies of the extracellular products of group A Streptococci. J Exp Med (1958) 2.82
The occurrence of nucleases in culture filtrates of group A hemolytic streptococci. J Exp Med (1948) 2.82
Toxinogeny in Corynebacterium diphtheriae. J Bacteriol (1961) 2.12
Induction of toxigenicity in non-toxigenic strains of C. diphtheriae with bacteriophages derived from non-toxigenic strains. Proc Soc Exp Biol Med (1955) 1.69
The use of precipitin analysis in agar for the study of human streptococcal infections. IV. Further observations on the purification of group A extracellular antigens. J Exp Med (1961) 1.26
Studies on streptococcal bacteriophages. 5. Serological investigation of phages isolated from 91 strains of group A haemolytic streptococci. Acta Pathol Microbiol Scand (1960) 1.11
[Isolation of phagosensitive bacteria from a lysogenic culture of Bacterium megaterium]. Arch Mikrobiol (1957) 0.97
Studies on streptococcal bacteriophages. 4. The occurrence of lysogenic strains among group A haemolytic streptococci. Acta Pathol Microbiol Scand (1960) 0.89
STUDIES ON THE PATHOGENESIS OF ACUTE AND PROGRESSIVE GLOMERULONEPHRITIS IN MAN BY IMMUNOFLUORESCEIN AND IMMUNOFERRITIN TECHNIQUES. Fed Proc (1965) 1.68
FLUORESCENT, ELECTRON MICROSCOPIC, AND IMMUNOELECTROPHORETIC STUDIES OF LABELED ANTIBODIES. Science (1963) 1.46
PNEUMONIA CAUSED BY TETRACYCLINE-RESISTANTPNEUMOCOCCI. N Engl J Med (1964) 1.44